# Innovation to augment the Lysosomal Acid Lipase Deficiency Treatment Market
Author:  Pal Sinha, Barnali 
Author URL: https://financedigest.com/author/pal-sinha-barnali
Published: 2021-12-13
Category: Research Reports
Category URL: https://financedigest.com/category/research-reports
Meta Title: Understanding Lysosomal Acid Lipase Deficiency: Causes,
Meta Description: Learn about the causes, symptoms, and treatment options for lysosomal acid lipase deficiency, an ultra-rare genetic disorder affecting less than 20 patients per
URL: https://financedigest.com/innovation-to-augment-the-lysosomal-acid-lipase-deficiency-treatment-markethtml

![undefined](https://prod.superblogcdn.com/site_cuid_cm5qst7v3003gwirgwqtxn8i8/images/research-report-2-1736836581944-compressed.jpg)

Lysosomal acid lipase deficiency (LAAL) is an autosomal recessive genetic disorder caused due to mutation in LIPE (Lipase E) gene which encodes the lysosomal acid lipase proteins on chromosome 10q23.31. Thus, due to mutation in LIPE gene there is no enough production of this active enzyme lysosomal acid lipase (LAAL) which leads to lysosomal acid lipase deficiency.

Basic function of lysosomal [acid lipase enzyme is to hydrolyze cholesterol esters](https://www.financedigest.com/propane-12-diol-esters-of-fatty-acid-market-2022-present-scenario-and-growth-prospects-2027.html "Propane-1,2-diol Esters Of Fatty Acid Market 2022 | Present Scenario and Growth Prospects 2027") and triglycerides. Lysosomal acid lipase deficiency phenotypic spectrum ranges from infantile to late-onset form, thus [leading to two types of lysosomal acid](https://www.financedigest.com/flooded-lead-acid-battery-regional-landscape-production-sales-consumption-status-and-prospects.html "Flooded Lead Acid Battery Regional Landscape, Production, Sales & Consumption Status and Prospects") lipase deficiency autosomal recessive diseases known as wolman disease and cholesterol ester storage disease (CESD) respectively.

Wolman disease is complete loss of lysosomal acid lipase enzyme occurring in infants with an incidence of about 1 in 500,000 of live births. It is characterized by diarrhea, vomiting, weight [loss which eventually leads](https://www.financedigest.com/easy-steal-blame-management-not-hackers-cyber-events-lead-losses.html "Too easy to steal: blame management, not hackers, when cyber events lead to losses.") to malnutrition, hepatomegaly or even death.

**Get Sample Copy of this Report@** [**https://www.persistencemarketresearch.com/samples/14569**](https://www.persistencemarketresearch.com/samples/14569)

Wolman disease results into hepatomegaly and [liver](https://www.financedigest.com/innovation-at-periodic-intervals-to-upscale-the-liver-disease-treatment-market.html "Innovation at periodic intervals to upscale the Liver Disease Treatment Market") disease due to deposition of cholesterol esters and triglycerides in hepatic macrophages. Wolman disease also leads to adrenal cortical insufficiency due to calcification of adrenal glands. It is mandatory in case of infants to undergo successful hematopoietic [stem cell](https://www.financedigest.com/the-stem-cell-therapy-market-to-get-digitally-amplified.html "The Stem Cell Therapy Market to get digitally amplified") transplantation in order to survive beyond a year. Cholesterol ester [storage disease can also occur in childhood and is characterized by partial loss of lysosomal](https://www.financedigest.com/the-lysosomal-storage-diseases-market-to-have-growth-devised-on-innovation.html "The Lysosomal Storage Diseases Market to have growth devised on innovation") acid lipase enzyme production with more varied presentation.

Cholesterol ester storage disease generally occurs late and in most cases is asymptomatic and underdiagnosed. Cholesterol ester storage disease has incidence of 1 in 40,000 individual, relatively high in comparison to Wolman disease. Cholesterol ester storage disease is indicated by hepatosplenomegaly, abnormalities in serum lipid and/or elevation of hepatic enzymes. Late-onset morbidity in cholesterol ester storage disease is due to atherosclerosis, anemia and/or thrombocytopenia, anemia and also liver diseases such as fibrosis, cirrhosis, and steatosis etc.

Lysosomal acid lipase deficiency results in [systemic complications due](https://www.financedigest.com/version-control-systems-market-gain-impetus-due-to-the-growing-demand-over-2017-2026.html "Version Control Systems Market Gain Impetus due to the Growing Demand over 2017 – 2026") to over deposition or accumulation of triglycerides and cholesteryl esters. Lysosomal acid lipase deficiency is an ultra-rare [disease affecting less than 20 patients per million population](https://www.financedigest.com/title-europe-direct-to-consumer-laboratory-testing-market-to-exhibit-26-cagr-by-2031-increasing-geriatric-population-and-growing-prevalence-of-infectious-diseases.html "Europe Direct-to-Consumer Laboratory Testing Market to Exhibit 26% CAGR by 2031; Increasing Geriatric Population and Growing Prevalence of Infectious Diseases"). Lysosomal acid lipase deficiency mainly causes multi-organ damage that might lead to death if not [treated on time](https://www.financedigest.com/shared-ownership-offers-first-time-buyers-treat-traders-quarter.html "Shared ownership offers first time buyers a treat at Traders’ Quarter"). Diagnosis of lysosomal acid lipase deficiency is done with help of sequencing of LIPA gene and also by measuring amount of lysosomal acid lipase enzyme present in peripheral blood leukocytes, dried blood spots or fibroblasts.

The [currently available treatment for lysosomal acid](https://www.financedigest.com/aspartic-acid-market-outlook-current-and-future-industry-landscape-analysis-2029.html "Aspartic Acid Market Outlook, Current and Future Industry Landscape Analysis 2029") lipase deficiency is intended to lower the cholesterol and triglycerides level with help of statins and cholestyramine. Maintaining levels of cholesterol and triglycerides prevents premature atherosclerosis. The lysosomal acid lipase deficiency treatment [market is expected to drive the market mainly due to the growing](https://www.financedigest.com/aluminum-foil-container-market-foreseen-to-grow-exponentially-over-2027.html "Aluminum Foil Container Market Foreseen to Grow Exponentially Over 2027") prevalence and lack of approved treatment for it, except for recently approved drug sebelipase alfa.

**Request for Table of Content@** [**https://www.persistencemarketresearch.com/toc/14569**](https://www.persistencemarketresearch.com/toc/14569)

This recent approval of sebelipase alfa drug is also [expected to drive the market for lysosomal acid lipase deficiency treatment](https://www.financedigest.com/provoked-vestibulodynia-treatment-market-expectations-and-growth-trends-highlighted-until-2028.html "Provoked Vestibulodynia Treatment Market Expectations and Growth Trends Highlighted Until 2028") market. [Challenges in lysosomal acid lipase deficiency treatment market](https://www.financedigest.com/analysis-ecb-qt-may-be-next-challenge-for-tumultuous-markets.html "Analysis-ECB ‘QT’ may be next challenge for tumultuous markets") is that unawareness of the people about LAAL deficiency. The lysosomal acid lipase deficiency treatment [market](https://www.financedigest.com/the-the-irritable-bowel-syndrome-treatment-market-to-subvert-monotony.html "The The Irritable Bowel Syndrome Treatment Market to subvert monotony") is also restrained by lack of thorough understanding about the disease as well as treatment.

The global [market for lysosomal acid lipase deficiency treatment](https://www.financedigest.com/the-dry-eye-syndrome-treatment-market-to-have-growth-devised-on-innovation.html "The Dry Eye Syndrome Treatment Market to have growth devised on innovation"), is segmented on basis of treatment type, disease indication and geography.

Treatment Type

- Enzyme replacement therapy
- Kidney transplantation
- [Stem cell](https://www.financedigest.com/the-stem-cell-banking-market-to-keep-up-the-digitized-momentum.html "The Stem Cell Banking Market to keep up the digitized momentum") transplantation

Disease Indication

- Wolman Disease Cholesterol ester storage disease (CESD)

Global lysosomal acid lipase deficiency treatment [market](https://www.financedigest.com/the-acne-treatment-market-to-imbibe-healthy-growth-by-innovation.html "The Acne Treatment Market to imbibe healthy growth by innovation") is segmented on basis of treatment type into enzyme replacement therapy, kidney transplantation and stem cell transplantation. FDA approval of drug sebelipase alfa on 8th December 2015 is considered to be a breakthrough in lysosomal acid lipase deficiency treatment market and thus enzyme replacement therapy segment is [expected](https://www.financedigest.com/wine-cooler-market-will-reach-valuation-of-us-2-bn-by-2018-and-is-expected-to-grow-at-cagr-5-6-for-2019-2029.html "Wine Cooler Market will reach valuation of US$ 2 Bn by 2018 and is expected to grow at CAGR ~ 5.6% for 2019–2029") to boost the lysosomal acid lipase deficiency treatment market.

While based on disease indication lysosomal acid lipase deficiency treatment market is segmented into wolman disease and cholesterol ester storage disease Cholesterol ester storage disease segment is expected to have a [greater share due to high demand](https://www.financedigest.com/stocks-with-greater-socially-responsible-investor-demand-saw-weaker-losses-during-the-covid-19-crash.html "Stocks with greater socially responsible investor demand saw weaker losses during the COVID-19 crash") in this segment.

**Access Full Report@** [**https://www.persistencemarketresearch.com/checkout/14569**](https://www.persistencemarketresearch.com/checkout/14569)

On basis of region or [country the lysosomal acid lipase deficiency treatment](https://www.financedigest.com/four-european-countries-call-for-special-treatment-of-defence-in-eu-debt-rules-document.html "Four European countries call for special treatment of defence in EU debt rules – document") market is segmented into North America (NA), Latin America (LA), Europe, Asia Pacific (APAC), Middle East and Africa (MEA). In terms of region, due to high prevalence of lysosomal acid lipase deficiency disease, Europe and North America are expected to boost lysosomal acid lipase deficiency [treatment market](https://www.financedigest.com/customized-innovation-to-drive-the-alopecia-treatment-market.html "Customized innovation to drive the Alopecia Treatment Market").

The major key players in the lysosomal acid lipase deficiency [treatment market](https://www.financedigest.com/pressure-relief-valves-for-water-and-wastewater-treatment-market-to-represent-a-significant-expansion-at-4-9-cagr-by-2021-to-2031-persistence-market-research.html "Pressure Relief Valves For Water And Wastewater Treatment Market To Represent A Significant Expansion At 4.9% CAGR By 2021 to 2031: Persistence Market Research") are, AstraZeneca plc., Merck & Co., Inc., Pfizer, Inc., Alexion Pharmaceutical Inc., Lonza Group Ltd., Thermo Fisher Scientific, Teva Pharmaceutical Industries Ltd.

**About Us:** [**Persistence Market Research**](https://www.persistencemarketresearch.com/about-us.asp)

**Contact Us:**

**[Persistence Market](https://www.financedigest.com/persistence-innovation-to-replenish-the-leather-luggage-and-goods-market.html "Persistence Innovation To Replenish The Leather Luggage And Goods Market") Research**

Address – 305 Broadway, 7th Floor, New [York City](https://www.financedigest.com/codex-raises-over-190000-usd-at-live-charity-auction-at-ethereal-summit-in-new-york-city.html "Codex Raises Over 0,000 USD at Live Charity Auction at Ethereal Summit in New York City"),

NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

**Japan Office:** 1-2-1 Kinshi Arca Central Building

14/F Tokyo, 130-0013, Japan

Call 1-888-863-3700

**Sales** – sales@persistencemarketresearch.com

**Website** – [https://www.persistencemarketresearch.com](https://www.persistencemarketresearch.com/)


---
This blog is powered by Superblog. Visit https://superblog.ai to know more.
---